Evidence map›Paper›PMID 42907158›Full record

ArticleJournal of the peripheral nervous system : JPNS2026

Intermittent Maple Syrup Urine Disease Presenting With Chronic Demyelinating Polyneuropathy: A Genetically Confirmed DBT-Related Case.

Gustavo Rodrigues Ferreira Gomes, Antonio Edvan Camelo Filho, Ellen Mourão Soares Lopes, Raquel Diógenes Alencar, Erlane Marques Ribeiro, Kécia Tavares de Oliveira, Paulo Ribeiro Nóbrega, André Luiz Santos Pessoa

Abstract readCase Reports
In one paragraph

Article in Journal of the peripheral nervous system : JPNS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gustavo Rodrigues Ferreira GomesDivision of Neurogenetics and Neuromuscular Disorders, Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil.ORCID https://orcid.org/0009-0005-1023-6708
Antonio Edvan Camelo FilhoDivision of Neurogenetics and Neuromuscular Disorders, Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil.ORCID https://orcid.org/0000-0002-1213-1687
Ellen Mourão Soares LopesDivision of Neurogenetics and Neuromuscular Disorders, Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil.ORCID https://orcid.org/0009-0008-7268-7514
Raquel Diógenes AlencarDivision of Neurogenetics and Neuromuscular Disorders, Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil.
Erlane Marques RibeiroDivision of Neurogenetics and Neuromuscular Disorders, Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil.ORCID https://orcid.org/0000-0002-7104-0128
Kécia Tavares de OliveiraDivision of Neurogenetics and Neuromuscular Disorders, Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil.
Paulo Ribeiro NóbregaFaculty of Medicine, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil.ORCID https://orcid.org/0000-0002-0021-9358
André Luiz Santos PessoaDivision of Neurogenetics and Neuromuscular Disorders, Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil.ORCID https://orcid.org/0000-0003-0043-5373

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsMaple syrup urine disease (MSUD) is an inherited disorder of branched-chain amino acid metabolism caused by deficiency of the branched-chain α-keto acid dehydrogenase complex. Neurological manifestations predominantly involve the central nervous system, whereas peripheral nervous system involvement has been rarely reported.

resultsWe report a genetically confirmed case of intermittent MSUD caused by compound heterozygous pathogenic variants in DBT in a female patient who developed recurrent ataxic episodes beginning in early childhood, followed by acute ascending weakness during metabolic decompensation at 12 years of age. Initially suspected to have Guillain-Barré syndrome, subsequent biochemical and molecular investigations established the diagnosis of MSUD. Five years later, despite good metabolic control and substantial functional recovery, follow-up nerve conduction studies, and electromyography demonstrated a chronic demyelinating sensorimotor polyneuropathy. Clinical examination additionally revealed bilateral pes cavus and persistent mild distal lower-limb weakness.

interpretationOnly a few cases of peripheral neuropathy associated with MSUD have previously been described. Our findings expand the phenotypic spectrum by documenting the longitudinal evolution from recurrent childhood neurological episodes to chronic mixed demyelinating-axonal polyneuropathy. The clinical course supports the hypothesis that repeated metabolic decompensation may contribute to cumulative peripheral nerve injury. Although the precise mechanisms remain uncertain, mitochondrial dysfunction, impaired energy metabolism, oxidative stress, and branched-chain amino acid and α-keto acid toxicity provide plausible explanations.

conclusionPeripheral neuropathy should be recognized as a potential manifestation of MSUD, including intermittent phenotypes. Long-term neurological follow-up incorporating electrophysiological evaluation may improve recognition of peripheral nervous system involvement and contribute to a more complete characterization of the disease.

Indexed as

3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)Maple Syrup Urine DiseaseChildFemaleHumansNerve Conduction StudiesNeural Conduction3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)EMGMSUDperipheral neuropathy

Identifiers

PMID42907158
PMCPMC13686809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.